Showing results (281-290 of 358) with videos related to

Sort By:
Pageof 36
Ebiomedicine|February 14, 2022
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's diseaseNicholas J Ashton, Andréa L Benedet, Tharick A Pascoal, et al.
Nature Communications|March 15, 2024
A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settingsWagner S Brum, Nicholas C Cullen, Joseph Therriault, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumIlaria Pola, Nicholas J Ashton, Marco Antônio De Bastiani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsDébora Guerini de Souza, Wyllians Vendramini Borelli, Fabiano Marcio Nagel, et al.
Brain, Behavior, and Immunity|March 6, 2023
Hippocampal GFAP-positive astrocyte responses to amyloid and tau pathologiesMarco Antônio De Bastiani, Bruna Bellaver, Wagner S Brum, et al.
Alzheimer'S Research & Therapy|February 19, 2025
The impact of kidney function on Alzheimer's disease blood biomarkers: implications for predicting amyloid-β positivityBurak Arslan, Wagner S Brum, Ilaria Pola, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsDouglas Teixeira Leffa, Guilherme Povala, Pamela C L Ferreira, et al.
Molecular Psychiatry|December 14, 2025
In vivo-measured Lewy body pathology is associated with neuropsychiatric symptoms across the Alzheimer's disease continuumDouglas Teixeira Leffa, Guilherme Povala, Pamela C L Ferreira, et al.
Brain, Behavior, and Immunity|June 9, 2019
Activated peripheral blood mononuclear cell mediators trigger astrocyte reactivityBruna Bellaver, Andréia S Rocha, Débora G Souza, et al.
Pageof 36